4-Methylmorpholine → N-[1-(4-Cyano-3-fluoro-phenyl)-1-(3-methyl-3H-imidazol-4-yl)-ethyl]-3-(3-methoxy-benzenesulfonylamino)-propionamide

HRID 1060883노트

반응식

HRID 1060883 반응식
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([S:9]([NH:12][CH2:13][CH2:14][C:15]([OH:17])=O)(=[O:11])=[O:10])[CH:6]=[CH:7][CH:8]=1.O.ON1C2C=CC=CC=2N=N1.Cl.C(N=C=NCCCN(C)C)C.CN1CCOCC1.[NH2:48][C:49]([C:57]1[CH:64]=[CH:63][C:60]([C:61]#[N:62])=[C:59]([F:65])[CH:58]=1)([C:51]1[N:52]([CH3:56])[CH:53]=[N:54][CH:55]=1)[CH3:50]>CN(C=O)C>[C:61]([C:60]1[CH:63]=[CH:64][C:57]([C:49]([NH:48][C:15](=[O:17])[CH2:14][CH2:13][NH:12][S:9]([C:5]2[CH:6]=[CH:7][CH:8]=[C:3]([O:2][CH3:1])[CH:4]=2)(=[O:10])=[O:11])([C:51]2[N:52]([CH3:56])[CH:53]=[N:54][CH:55]=2)[CH3:50])=[CH:58][C:59]=1[F:65])#[N:62]

참가 물질

7

실험 절차

To a solution of 3-(3-methoxy-benzenesulfonylamino)-propionic acid (0.261 g, 1.01 mmol) in DMF (4 mL) at room temperature was added 1-hydroxybenzotriazole hydrate (HOBT) (0.146 g, 0.96 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) (0.202 g, 1.05 mmol), 4-methylmorpholine (0.102 g, 1.01 mmol), and (+)-4-[1-amino-1-(3-methyl-3H-imidazol-4-yl)-ethyl]-2-fluoro-benzonitrile (Step I) (0.246 g, 1.01 mmol). After stirring overnight, the reaction was concentrated in vacuo. The residue was partitioned between EtOAc and water, the organic layer separated, washed with brine, dried (Na2SO4), and concentrated in vacuo to provide the title compound after purification by chromatography on silica gel (5% to 7.5% methanol/0.1% ammonium hydroxide in CH2Cl2).

후처리

  1. concentrationthe reaction was concentrated in vacuo
  2. customThe residue was partitioned between EtOAc and water
  3. customthe organic layer separated
  4. washwashed with brine
  5. dry with materialdried (Na2SO4)
  6. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-9a812b670a83421bb69e7bd9d44c305a
출처 데이터셋
uspto-grants-2003_02
특허 번호
US06525074B2

반응 노트

불러오는 중…